Broncho-alveolar lavage matrix metalloproteases as a sensitive measure of bronchiolitis obliterans

被引:46
作者
Taghavi, S
Krenn, K
Jaksch, P
Klepetko, W
Aharinejad, S
机构
[1] Vienna Med Univ, Dept Cardiothorac Surg, Vienna, Austria
[2] Vienna Med Univ, Ctr Anat & Cell Biol, Cardiovasc Res Lab, Vienna, Austria
关键词
bronchiolitis obliterans; ELISA; lung transplantation; marker; matrix metalloproteases;
D O I
10.1111/j.1600-6143.2005.00865.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Bronchiolitis obliterans (BO) is a survival-limiting factor in lung transplantation. There are no common BO markers in use. Since BO is associated with extracellular matrix remodeling, we asked whether matrix metalloproteases (MMPs) and their tissue inhibitors (TIMPs) could serve as BO markers. In 72 lung transplant patients (34 BO syndrome (BOS) 0, 15 BOS 0-p, and 23 BOS 1) serum and broncho-alveolar lavage (BAL) MMP and TIMP levels were examined by ELISA. The BAL cell counts were additionally analyzed. The serum MMP-2, MMP-8, MMP-9 and TIMP-2 levels were not different in all groups. In contrast, the BAL MMP-8, -9 and TIMP-1 levels were significantly elevated in BOS 0-p (p = 0.003; p = 0.007; p = 0.0003, respectively) and BOS 1 (p = 0.003; p = 0.001; p = 0.0004, respectively) as compared to BOS 0 patients. The BAL MMP-8, -9 and TIMP-1 levels were significant predictors of BOS 0-p (p = 0.01; p = 0.01; p = 0.01, respectively) and BOS-1 (p = 0.007; p = 0.01; p = 0.006, respectively) in receiver operating characteristic analysis. Except for BAL macrophages that were significantly decreased in BOS 0-p versus BOS 0 patients; other cell counts were not different between the groups. BAL MMP-8, -9 and TIMP-1 might be useful markers to detect BO in lung transplant patients.
引用
收藏
页码:1548 / 1552
页数:5
相关论文
共 20 条
  • [1] Prediction of lung-transplant rejection by hepatocyte growth factor
    Aharinejad, S
    Taghavi, S
    Klepetko, W
    Abraham, D
    [J]. LANCET, 2004, 363 (9420) : 1503 - 1508
  • [2] Medical progress - Lung transplantation
    Arcasoy, SM
    Kotloff, RM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (14) : 1081 - 1091
  • [3] OBLITERATIVE BRONCHIOLITIS AFTER LUNG AND HEART-LUNG TRANSPLANTATION - AN ANALYSIS OF RISK-FACTORS AND MANAGEMENT
    BANDO, K
    PARADIS, IL
    SIMILO, S
    KONISHI, H
    KOMATSU, K
    ZULLO, TG
    YOUSEM, SA
    CLOSE, JM
    ZEEVI, A
    DUQUESNOY, RJ
    MANZETTI, J
    KEENAN, RJ
    ARMITAGE, JM
    HARDESTY, RL
    GRIFFITH, BP
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (01) : 4 - 14
  • [4] Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients:: Relation to tumor necrosis factor-α and interleukin-10
    Beeh, KM
    Beier, J
    Kornmann, O
    Micke, P
    Buhl, R
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (11) : 1144 - 1151
  • [5] Boehler A, 2000, Curr Opin Pulm Med, V6, P133, DOI 10.1097/00063198-200003000-00009
  • [6] Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury
    Corbel, M
    Boichot, E
    Lagente, V
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2000, 33 (07) : 749 - 754
  • [7] Alveolar neutrophilia is a predictor for the bronchiolitis obliterans syndrome, and increases with degree of severity
    Devouassoux, G
    Drouet, C
    Pin, I
    Brambilla, C
    Brambilla, E
    Colle, PE
    Pison, C
    [J]. TRANSPLANT IMMUNOLOGY, 2002, 10 (04) : 303 - 310
  • [8] Transforming growth factor beta (TGF-β) and obliterative bronchiolitis following pulmonary transplantation
    El-Gamel, A
    Sim, E
    Hasleton, P
    Hutchinson, J
    Yonan, N
    Egan, J
    Campbell, C
    Rahman, A
    Sheldon, S
    Deiraniya, A
    Hutchinson, IV
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (09) : 828 - 837
  • [9] Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria
    Estenne, M
    Maurer, JR
    Boehler, A
    Egan, JJ
    Frost, A
    Hertz, M
    Mallory, GB
    Snell, GI
    Yousem, S
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (03) : 297 - 310
  • [10] Girgis RE, 1996, J HEART LUNG TRANSPL, V15, P1200